Browsing by keyword "treatment retention"
Now showing items 1-3 of 3
-
Transdiagnostic Motivational Enhancement Therapy to Reduce Treatment Attrition: Use in Emerging AdultsImproving outcomes of youth with mental health (MH) needs as they transition into adulthood is of critical public health significance. Effective psychotherapy MH treatment is available, but can be effective only if the emerging adult (EA) attends long enough to benefit. Unfortunately, completion of psychotherapy among EAs is lower than for more mature adults (Edlund et al., 2002; Olfson, Marcus, Druss, and Pincus, 2002). To target the high attrition of EAs in MH treatment, investigators adapted a developmentally appropriate brief intervention aimed at reducing treatment attrition (TA) in psychotherapy and conducted a feasibility study of implementation. The intervention employs motivational interviewing strategies aimed at engaging and retaining EAs in outpatient MH treatment. Motivational enhancement therapy for treatment attrition, or MET-TA, takes only a few sessions at the outset of treatment as an adjunct to usual treatment. Importantly, it can be used for TA with psychotherapy for any MH condition; in other words, it is transdiagnostic. This article presents the first description of MET-TA, along with a case example that demonstrates important characteristics of the approach, and then briefly describes implementation feasibility based on a small pilot randomized controlled trial.
-
Transition-Age Youth Psychotherapy Experiences (TYPE) Study [English and Spanish versions]This Research in the Works product describes the Transitions RTC’s Transition-Age Youth Psychotherapy Experiences (TYPE) Study. The goal of the TYPE study is to better understand 1) TAY-specific factors that contribute to treatment attrition or retention; and 2) the degree to which adult retention interventions apply to TAY. A Spanish translation of this publication is available for download.
-
Treatment Retention Strategies in Transition Age YouthThis study tests Motivational Interviewing as a treatment retention intervention in transition age youth to determine whether sufficient evidence can be found to justify a full scale clinical trial.


